Difficulty: Medium
Average Score: 63%
Practice
Tardive dyskinesia is the result of:
Correct answer
B
Rationale
The correct answer is B) Hyperactive dopaminergic state in the presence of dopamine blockers. Tardive dyskinesia is a movement disorder characterized by involuntary, repetitive movements, often seen as a side effect of long-term use of dopamine-blocking medications such as antipsychotics. These medications block dopamine receptors, leading to an increase in dopaminergic activity to compensate, which can result in hyperactivity and dysregulation of dopaminergic pathways, ultimately causing tardive dyskinesia.
Option A) Degeneration of dopaminergic and cholinergic fibers is incorrect because tardive dyskinesia is not primarily caused by degeneration of these fibers but rather by the dysregulation of dopaminergic pathways.
Option C) Degeneration of histaminergic fibers is incorrect as histaminergic fibers are not primarily involved in the pathophysiology of tardive dyskinesia.
Option D) Supersensitivity of cholinergic receptors in the caudate-putamen is incorrect as cholinergic receptors are not the primary target in the development of tardive dyskinesia associated with dopamine blockade.
Understanding the pathophysiology of tardive dyskinesia is crucial for healthcare professionals, especially those prescribing antipsychotic medications, as it highlights the importance of monitoring patients for potential adverse effects and considering alternative treatment options to minimize the risk of developing this debilitating condition.
Option A) Degeneration of dopaminergic and cholinergic fibers is incorrect because tardive dyskinesia is not primarily caused by degeneration of these fibers but rather by the dysregulation of dopaminergic pathways.
Option C) Degeneration of histaminergic fibers is incorrect as histaminergic fibers are not primarily involved in the pathophysiology of tardive dyskinesia.
Option D) Supersensitivity of cholinergic receptors in the caudate-putamen is incorrect as cholinergic receptors are not the primary target in the development of tardive dyskinesia associated with dopamine blockade.
Understanding the pathophysiology of tardive dyskinesia is crucial for healthcare professionals, especially those prescribing antipsychotic medications, as it highlights the importance of monitoring patients for potential adverse effects and considering alternative treatment options to minimize the risk of developing this debilitating condition.